electroCore, Inc. ECOR

FY2025 · ended Dec 31, 2025 · Revenue $32.03M, +27.2% YoY · Filed Mar 19, 2026

electroCore, Inc. (ECOR) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $32.0 million and a net loss of $14.0 million. Free cash flow was -$8.3 million. As of Sep 30, 2026 it held $7.5 million in cash and investments and $11.0 million in total debt.

Revenue (TTM)
$37.97M
+27.3% vs year-ago TTM
Net income (TTM)
$-12.70M
+10.3% vs year-ago TTM
Operating cash flow (TTM)
$-10.89M
-37.9% vs year-ago TTM
Free cash flow (TTM)
$-10.90M
-36.1% vs year-ago TTM
EPS (TTM)
$-15.44
-580.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
8.08M
+12.4% vs prior year
Net cash
$-3.52M
as of Sep 30, 2026
Operating margin
-33.1%
FY 2026

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ECOR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Rockaway, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1560258
Former names
ElectroCore, LLC (until Jun 20, 2018)

Other Electromedical & Electrotherapeutic Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$32.0M
$25.2M
$16.0M
$8.6M
$5.5M
Operating income
-$13.2M
-$12.2M
-$19.3M
-$22.9M
-$20.0M
Net income
-$14.0M
-$11.9M
-$18.8M
-$22.2M
-$17.2M
Diluted EPS
-$1.65
-$1.59
-$3.42
-$4.69
—
Operating cash flow
-$8.2M
-$6.9M
-$14.7M
-$16.6M
-$13.6M
Free cash flow
-$8.3M
—
-$14.9M
—
—
Total assets
$18.7M
$20.5M
$16.1M
$24.8M
$42.8M
Total liabilities
$20.4M
$12.9M
$8.7M
$7.7M
$6.2M
Stockholders' equity
-$1.7M
$7.5M
$7.4M
$17.1M
$36.6M
Cash and investments
$11.6M
$12.2M
$10.3M
$17.7M
$34.7M
Total debt
$10.6M
$4.1M
$626,000
$699,000
$761,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Sep 9, 2026 Sep 8, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.